Plk3 phosphorylates topoisomerase IIα at Thr1342, a site that is not recognized by Plk1

Biochemical Journal

Volumn 411, Issue 1, 2008, Pages 27-32

  Iida, Masato ^a   Matsuda, Masao ^a   Komatani, Hideya ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Consensus sequence; Peptide substrate; Plk3; Protein kinase; Substrate specificity; Topoisomerase II

Indexed keywords

CONSENSUS SEQUENCE; PEPTIDE SUBSTRATES; PLK3; PROTEIN KINASE; SUBSTRATE SPECIFICITY;

CELL CULTURE; PEPTIDES; PHOSPHORYLATION; PHYSIOLOGICAL MODELS;

ENZYME KINETICS;

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; POLO LIKE KINASE 1; POLO LIKE KINASE 3; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE REGULATION; EMBRYO; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CELL CYCLE; CELL CYCLE PROTEINS; CONSENSUS SEQUENCE; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; HUMANS; PEPTIDES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SUBSTRATE SPECIFICITY; THREONINE;

EID: 41649094151     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071394     Document Type: Article

References (45)

1. Sunkel, C. E. and Glover, D. M. (1988) Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J. Cell Sci. 89, 25-38
2. Glover, D. M., Hagan, I. M. and Tavares, A. A. (1998) Polo-like kinases: a team that plays throughout mitosis. Genes Dev. 12, 3777-3787
3. van de Weerdt, B. C. and Medema, R. H. (2006) Polo-like kinases: a team in control of the division. Cell Cycle 5, 853-864
4. Lane, H. A. and Nigg, E. A. (1996) Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J. Cell Biol. 135, 1701-1713
5. do Carmo Avides, M., Tavares, A. and Glover, D. M. (2001) Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes. Nat. Cell Biol. 3, 421-424
6. Kumagai, A. and Dunphy, W. G. (1996) Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts. Science 273, 1377-1380
7. Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M. A. and Nasmyth, K. (2001) Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast. Cell 105, 459-472
8. Kotani, S., Tugendreich, S., Fujii, M., Jorgensen, P. M., Watanabe, N., Hoog, C., Hieter, P. and Todokoro, K. (1998) PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol. Cell 1, 371-380
9. Liu, X. and Erikson, R. L. (2002) Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc. Natl. Acad. Sci. U.S.A. 99, 8672-8676
10. Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M. and Strebhardt, K. (2002) Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J. Natl. Cancer Inst. 94, 1863-1877
11. Liu, X. and Erikson, R. L. (2003) Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 5789-5794
12. Lansing, T. J., McConnell, R. T., Duckett, D. R., Spehar, G. M., Knick, V. B., Hassler, D. F., Nora, N., Furuta, M., Emmitte, K. A., Gilmer, T. M. et al. (2007) In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol. Cancer. Ther. 6, 450-459
13. Steegmaier, M., Hoffmann, M., Baum, A., Lenart, P., Petronczki, M., Krssak, M., Gurtler, U., Garin-Chesa, P., Lieb, S., Quant, J. et al. (2007) BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol. 17, 316-322
14. Bahassi, el M., Hennigan, R. F., Myer, D. L. and Stambrook, P. J. (2004) Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation. Oncogene 23, 2658-2663
15. Ruan, Q., Wang, Q., Xie, S., Fang, Y., Darzynkiewicz, Z., Guam, K., Jhanwar-Uniyal, M. and Dai, W. (2004) Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle. Exp. Cell Res. 294, 51-59
16. Xie, S., Wu, H., Wang, Q., Cogswell, J. P., Husain, I., Conn, C., Stambrook, P., Jhanwar-Uniyal, M. and Dai, W. (2001) Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J. Biol. Chem. 276, 43305-43312
17. Xie, S., Wang, Q., Wu, H., Cogswell, J., Lu, L., Jhanwar-Uniyal, M. and Dai, W. (2001) Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J. Biol. Chem. 276, 36194-36199
18. Li, Z., Niu, J., Uwagawa, T., Peng, B. and Chiao, P. J. (2005) Function of polo-like kinase 3 in NF-κB-mediated proapoptotic response. J. Biol. Chem. 280, 16843-16850
19. Nakajima, H., Toyoshima-Morimoto, F., Taniguchi, E. and Nishida, E. (2003) Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J. Biol. Chem. 278, 25277-25280
20. Johnson, E. F., Stewart, K. D., Woods, K. W., Giranda, V. L. and Luo, Y. (2007) Pharmacological and functional comparison of the Polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry 46, 9551-9563
21. Wang, J. C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell. Biol. 3, 430-440
22. Woessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K. and Drake, F. H. (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ. 2, 209-214
23. Kimura, K., Saijo, M., Ui, M. and Enomoto, T. (1994) Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase. J. Biol. Chem. 269, 1173-1176
24. Lucas, I., Germe, T., Chevrier-Miller, M. and Hyrien, O. (2001) Topoisomerase II can unlink replicating DNA by precatenane removal. EMBO J. 20, 6509-6519
25. Clarke, D. J., Johnson, R. T. and Downes, C. S. (1993) Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J. Cell Sci. 105, 563-569
26. Ackerman, P., Glover, C. V. and Osheroff, N. (1985) Phosphorylation of DNA topoisomerase II by casein kinase II: modulation ot eukaryotic topoisomerase II activity in vitro. Proc. Natl. Acad. Sci. U.S.A. 82, 3164-3168
27. Bojanowski, K., Filhol, O., Cochet, C., Chambaz, E. M. and Larsen, A. K. (1993) DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active. J. Biol. Chem. 268, 22920-22926
28. Cardenas, M. E., Walter, R., Hanna, D. and Gasser, S. M. (1993) Casein kinase II copurifies with yeast DNA topoisomerase II and re-activates the dephosphorylated enzyme. J. Cell Sci. 104, 533-543
29. Corbett, A. H., DeVore, R. F. and Osheroff, N. (1992) Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis. J. Biol. Chem. 267, 20513-20518
30. DeVore, R. F., Corbett, A. H. and Osheroff, N. (1992) Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4′-(9-acridinylamino)methane-sulfon-m- anisidide. Cancer Res. 52, 2156-2161
31. Corbett, A. H., Fernald, A. W. and Osheroff, N. (1993) Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation. Biochemistry 32, 2090-2097
32. Sahyoun, N., Wolf, M., Besterman, J., Hsieh, T., Sander, M., LeVine, 3rd, H., Chang, K. J. and Cuatrecasas, P. (1986) Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc. Natl. Acad. Sci. U.S.A. 83, 1603-1607
33. Rottmann, M., Schroder, H. C., Gramzow, M., Renneisen, K., Kurelec, B., Dorn, A., Friese, U. and Mullet, W. E. (1987) Spedlic phosphorylation of proteins in pore complex-laminae from the sponge Geodia cydonium by the homologous aggregation factor and phorbol ester. Role of protein kinase C in the phosphorylation of DNA topoisomerase II. EMBO J. 6, 3939-3944
34. Toyoshima-Morimoto, F., Taniguchi, E., Shinya, N., Iwamatsu, A. and Nishida, E. (2001) Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 410, 215-220
35. Toyoshima-Morimoto, F., Taniguchi, E. and Nishida, E. (2002) Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep. 3, 341-348
36. Yuan, J., Eckerdt, F., Bereiter-Hahn, J., Kurunci-Csacsko, E., Kaufmann, M. and Strebhardt, K. (2002) Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene 21, 8282-8292
37. Ishida, R., Iwai, M., Marsh, K. L., Austin, C. A., Yano, T., Shibata, M., Nozaki, N. and Hara, A. (1996) Threonine 1342 in human topoisomerase IIα is phosphorylated throughout the cell cycle. J. Biol. Chem. 271, 30077-30082
38. Daum, J. R. and Gorbsky, G. J. (1998) Casein kinase II catalyzes a mitotic phosphorylation on threonine 1342 of human DNA topoisomerase IIα, which is recognized by the 3F3/2 phosphoepitope antibody. J. Biol. Chem. 273, 30622-30629
39. Songyang, Z., Lu, K., P., Kwon, Y. T., Tsai, L. H., Filhol, O., Cochet, C., Brickey, D. A., Soderling, T. R., Bartleson, C., Graves, D. J. et al. (1996) A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II. NIMA, Phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell Biol. 16, 6486-6493
40. Ishida, R., Miki, T., Narita, T., Yui, R., Sato, M., Utsumi, K. R., Tanabe, K. and Andoh, T. (1991) Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: moue of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res 51, 4909-4916
41. Lou, Z., Minter-Dykhouse, K. and Chen, J. (2005) BRCA1 participates in DNA decatenation. Nat. Struct. Mol. Biol. 12, 589-593
42. Chase, D., Feng, Y., Hanshew, B., Winkles, J. A., Longo, D. L. and Ferris, D. K. (1998) Expression and phosphorylation of fibroblast-growth-factor- inducible kinase (Fnk) during cell-cycle progression. Biochem. J. 333, 655-660
43. 2 cycle checkpoint in mammalian cells. Nature 372, 467-470
44. Xie, S., Wu, H., Wang, Q., Kunicki, J., Thomas, R. O., Hollingsworth, R. E., Cogswell, J. and Dai, W. (2002) Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2. Cell Cycle 1, 424-429
45. Bahassi, el M., Conn, C. W., Myer, D. L., Hennigan, R. F., McGowan, C. H., Sanchez, Y. and Stambrook, P. J. (2002) Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 21, 6633-6640